Silverarc-Capital-Management

AI_NATIVE detailed information: This accession holds the following tickers:[
  "OCUL",
  "MRUS",
  "AKRO",
  "KNSA",
  "NUVL",
  "ASND",
  "TRVI",
  "CNTA",
  "ALKS",
  "INSM",
  "ORIC",
  "MDGL",
  "PTCT",
  "VCYT",
  "ABVX",
  "AVDL",
  "GPCR",
  null,
  "TVTX",
  "LQDA",
  "MLYS",
  "SNDX",
  "GILD",
  "GUTS",
  "TARS",
  null,
  "NBIX",
  "KALA",
  "KALV",
  "MRSN",
  null,
  "MODD",
  null,
  "TELA",
  "UNCY",
  "BNTC",
  "BDSX",
  "IFRX",
  null,
  null,
  null,
  "RNA",
  "SLDB",
  "PRAX",
  "RYTM",
  "SLNO",
  "QURE",
  "ETNB",
  null,
  "GOSS",
  "WVE",
  "CGEN",
  "ERAS",
  null,
  "DCTH",
  "KURA",
  "KOD",
  "URGN",
  "VRNA",
  "VXRT",
  "XENE",
  "BPMC",
  "BBIO",
  "CCCC",
  "CLDX",
  "CERS",
  "CMPX",
  "DNTH",
  "IRON"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-14
Total Holdings: 69
Total Value: 488995340
Accession Number: 0001420506-25-001107
Form Type: 13F-HR
CIK: silverarc-capital-management
Manager Name: Silverarc-Capital-Management

Data Enrichment

87% identified

60 identified9 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

69 positions • $489.0M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 2 of 4

Sort by:

00973Y908

Shares:180.6K

Value:$7.3M

% of Portfolio:1.5% ($7.3M/$489.0M)

Gossamer Bio, Inc.

GOSS|38341P102

Shares:6.3M

Value:$7.0M

% of Portfolio:1.4% ($7.0M/$489.0M)

GILEAD SCIENCES, INC.

GILD|375558103

Shares:62.0K

Value:$7.0M

% of Portfolio:1.4% ($7.0M/$489.0M)

G4444H101

Shares:613.4K

Value:$6.9M

% of Portfolio:1.4% ($6.9M/$489.0M)

05479K106

Shares:2.7M

Value:$6.8M

% of Portfolio:1.4% ($6.8M/$489.0M)

Praxis Precision Medicines, Inc.

PRAX|74006W207

Shares:166.1K

Value:$6.3M

% of Portfolio:1.3% ($6.3M/$489.0M)

Mineralys Therapeutics, Inc.

MLYS|603170101

Shares:338.4K

Value:$5.4M

% of Portfolio:1.1% ($5.4M/$489.0M)

COMPUGEN LTD

CGEN|M25722105

Shares:2.9M

Value:$4.2M

% of Portfolio:0.9% ($4.2M/$489.0M)

Tarsus Pharmaceuticals, Inc.

TARS|87650L103

Shares:81.3K

Value:$4.2M

% of Portfolio:0.9% ($4.2M/$489.0M)

Alkermes plc.

ALKS|G01767105

Shares:124.9K

Value:$4.1M

% of Portfolio:0.8% ($4.1M/$489.0M)

OCULAR THERAPEUTIX, INC

OCUL|67576A100

Shares:551.6K

Value:$4.0M

% of Portfolio:0.8% ($4.0M/$489.0M)

BridgeBio Pharma, Inc.

BBIO|10806X102

Shares:111.0K

Value:$3.8M

% of Portfolio:0.8% ($3.8M/$489.0M)

Kura Oncology, Inc.

KURA|50127T109

Shares:581.4K

Value:$3.8M

% of Portfolio:0.8% ($3.8M/$489.0M)

Celldex Therapeutics, Inc.

CLDX|15117B202

Shares:206.0K

Value:$3.7M

% of Portfolio:0.8% ($3.7M/$489.0M)

Dianthus Therapeutics, Inc. /DE/

DNTH|252828108

Shares:190.3K

Value:$3.5M

% of Portfolio:0.7% ($3.5M/$489.0M)

MADRIGAL PHARMACEUTICALS, INC.

MDGL|558868105

Shares:10.3K

Value:$3.4M

% of Portfolio:0.7% ($3.4M/$489.0M)

CERUS CORP

CERS|157085101

Shares:2.5M

Value:$3.4M

% of Portfolio:0.7% ($3.4M/$489.0M)

TELA Bio, Inc.

TELA|872381108

Shares:2.8M

Value:$3.4M

% of Portfolio:0.7% ($3.4M/$489.0M)

Centessa Pharmaceuticals plc

CNTA|152309100

Shares:232.8K

Value:$3.3M

% of Portfolio:0.7% ($3.3M/$489.0M)

Trevi Therapeutics, Inc.

TRVI|89532M101

Shares:530.0K

Value:$3.3M

% of Portfolio:0.7% ($3.3M/$489.0M)

Instrument	Shares		Other Manager	Value	% of Portfolio
(cusip00973Y908)✕	180.6K	QoQ -17.90% (-39.4K) YoY NEW(+180.6K)	All Managers (Combined)	$7.3M	1.5% ($7.3M/$489.0M)	QoQ +19.44% (-$1.2M) YoY NEW(+$7.3M)
Gossamer Bio, Inc.(GOSScusip38341P102)	6.3M	QoQ +2.41% (+148.8K) YoY +3.10% (-190.4K)	All Managers (Combined)	$7.0M	1.4% ($7.0M/$489.0M)	QoQ +24.53% (+$1.4M) YoY -3.88% (-$281.0K)
GILEAD SCIENCES, INC.(GILDcusip375558103)	62.0K	QoQ +520.29% (+52.0K) YoY NEW(+62.0K)	All Managers (Combined)	$7.0M	1.4% ($7.0M/$489.0M)	QoQ +652.44% (+$6.0M) YoY NEW(+$7.0M)
(cusipG4444H101)✕	613.4K	QoQ +19.48% (+100.0K) YoY +22.67% (+113.4K)	All Managers (Combined)	$6.9M	1.4% ($6.9M/$489.0M)	QoQ +28.58% (+$1.5M) YoY +33.29% (+$1.7M)
(cusip05479K106)✕	2.7M	QoQ +49.81% (+887.8K) YoY +3297.88% (+2.6M)	All Managers (Combined)	$6.8M	1.4% ($6.8M/$489.0M)	QoQ +1.34% (+$89.5K) YoY +2629.09% (+$6.5M)
Praxis Precision Medicines, Inc.(PRAXcusip74006W207)	166.1K	QoQ +129.01% (+93.6K) YoY -12.84% (-24.5K)	All Managers (Combined)	$6.3M	1.3% ($6.3M/$489.0M)	QoQ +12.69% (+$708.4K) YoY -45.91% (-$5.3M)
Mineralys Therapeutics, Inc.(MLYScusip603170101)	338.4K	QoQ NEW(+338.4K) YoY +494.18% (+281.4K)	All Managers (Combined)	$5.4M	1.1% ($5.4M/$489.0M)	QoQ NEW(+$5.4M) YoY +630.88% (+$4.6M)
COMPUGEN LTD(CGENcusipM25722105)	2.9M	QoQ +78.24% (+1.3M) YoY +189.54% (+1.9M)	All Managers (Combined)	$4.2M	0.9% ($4.2M/$489.0M)	QoQ +70.09% (+$1.7M) YoY +63.84% (+$1.6M)
Tarsus Pharmaceuticals, Inc.(TARScusip87650L103)	81.3K	QoQ +23.31% (+15.4K) YoY NEW(+81.3K)	All Managers (Combined)	$4.2M	0.9% ($4.2M/$489.0M)	QoQ +14.40% (+$526.0K) YoY NEW(+$4.2M)
Alkermes plc.(ALKScusipG01767105)	124.9K	QoQ NEW(+124.9K) YoY NEW(+124.9K)	All Managers (Combined)	$4.1M	0.8% ($4.1M/$489.0M)	QoQ NEW(+$4.1M) YoY NEW(+$4.1M)
OCULAR THERAPEUTIX, INC(OCULcusip67576A100)	551.6K	QoQ NEW(+551.6K) YoY NEW(+551.6K)	All Managers (Combined)	$4.0M	0.8% ($4.0M/$489.0M)	QoQ NEW(+$4.0M) YoY NEW(+$4.0M)
BridgeBio Pharma, Inc.(BBIOcusip10806X102)	111.0K	QoQ NEW(+111.0K) YoY NEW(+111.0K)	All Managers (Combined)	$3.8M	0.8% ($3.8M/$489.0M)	QoQ NEW(+$3.8M) YoY NEW(+$3.8M)
Kura Oncology, Inc.(KURAcusip50127T109)	581.4K	QoQ NEW(+581.4K) YoY NEW(+581.4K)	All Managers (Combined)	$3.8M	0.8% ($3.8M/$489.0M)	QoQ NEW(+$3.8M) YoY NEW(+$3.8M)
Celldex Therapeutics, Inc.(CLDXcusip15117B202)	206.0K	QoQ -22.14% (-58.6K) YoY -31.18% (-93.4K)	All Managers (Combined)	$3.7M	0.8% ($3.7M/$489.0M)	QoQ -44.08% (-$2.9M) YoY -70.24% (-$8.8M)
Dianthus Therapeutics, Inc. /DE/(DNTHcusip252828108)	190.3K	QoQ NEW(+190.3K) YoY NEW(+190.3K)	All Managers (Combined)	$3.5M	0.7% ($3.5M/$489.0M)	QoQ NEW(+$3.5M) YoY NEW(+$3.5M)
MADRIGAL PHARMACEUTICALS, INC.(MDGLcusip558868105)	10.3K	QoQ NEW(+10.3K) YoY NEW(+10.3K)	All Managers (Combined)	$3.4M	0.7% ($3.4M/$489.0M)	QoQ NEW(+$3.4M) YoY NEW(+$3.4M)
CERUS CORP(CERScusip157085101)	2.5M	QoQ +54.76% (+869.3K) YoY +67.59% (+990.8K)	All Managers (Combined)	$3.4M	0.7% ($3.4M/$489.0M)	QoQ +39.69% (+$970.3K) YoY +23.25% (+$644.3K)
TELA Bio, Inc.(TELAcusip872381108)	2.8M	QoQ -9.60% (-294.4K) YoY +256.73% (-2.0M)	All Managers (Combined)	$3.4M	0.7% ($3.4M/$489.0M)	QoQ -63.48% (-$5.9M) YoY -23.24% (-$1.0M)
Centessa Pharmaceuticals plc(CNTAcusip152309100)	232.8K	QoQ -61.13% (-366.2K) YoY NEW(+232.8K)	All Managers (Combined)	$3.3M	0.7% ($3.3M/$489.0M)	QoQ -66.63% (-$6.7M) YoY NEW(+$3.3M)
Trevi Therapeutics, Inc.(TRVIcusip89532M101)	530.0K	QoQ -27.81% (-204.2K) YoY -37.22% (-314.2K)	All Managers (Combined)	$3.3M	0.7% ($3.3M/$489.0M)	QoQ +10.20% (-$308.7K) YoY +14.45% (-$421.1K)